Free US stock correlation to major indices and sector benchmarks for performance attribution analysis and return source identification. We help you understand how your portfolio moves relative to broader market benchmarks and identify return drivers. We provide correlation analysis, attribution breakdown, and benchmark comparison for comprehensive coverage. Understand performance drivers with our comprehensive correlation and attribution analysis tools for portfolio optimization.
Candel Therapeutics Inc. (CADL) is a clinical-stage biotech company focused on developing novel immunotherapy treatments for oncology indications. As of April 18, 2026, CADL shares are trading at $6.37, representing a 23.45% gain in recent trading sessions, marking one of the more notable short-term price moves among small-cap biotech names this month. This analysis evaluates key technical levels, recent market context, and potential near-term price action scenarios for the stock, with no recent
How to Value Candel (CADL) Stock (Bullish Sentiment) 2026-04-18 - Volatility Breakout
CADL - Stock Analysis
3690 Comments
1669 Likes
1
Chaswick
Expert Member
2 hours ago
Missed the memo… oof.
👍 58
Reply
2
Lilyane
Experienced Member
5 hours ago
This is exactly what I was looking for last night.
👍 225
Reply
3
Trajon
Loyal User
1 day ago
That idea just blew me away! 💥
👍 236
Reply
4
Ike
Power User
1 day ago
I’m looking for people who noticed the same thing.
👍 38
Reply
5
Rendi
Consistent User
2 days ago
Markets are reacting cautiously to economic data releases.
👍 115
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.